Sökning: "HSCT"
Visar resultat 1 - 5 av 82 avhandlingar innehållade ordet HSCT.
1. Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden
Sammanfattning : This thesis investigated the efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) as a treatment of multiple sclerosis. This thesis demonstrates that when compared to one of the most powerful disease-modifying drugs (DMDs), specifically alemtuzumab (ALZ), AHSCT is able to hold its ground. LÄS MER
2. Diversity and focus of CMV specific T-cell responses in patients post-HSCT and with solid tumor
Sammanfattning : Human Cytomegalovirus (CMV) is a beta-herpesvirus that commonly infects humans. Most symptoms in healthy individuals are very mild. The virus is never eliminated and remains in the individual life-long. Thus, CMV and the immune response stay in coexistence until the protective response remains. LÄS MER
3. Infections in allogeneic stem cell transplanted patients : clinical and immunological aspects
Sammanfattning : In allogeneic haematopoietic stem cell transplantation (HSCT), 30 to 40 % of transplant related mortality is associated with infection complications. This includes invasive bacterial and fungal infection, and interstitial pneumonia (IP), which are two important causes of morbidity and mortality. LÄS MER
4. Late effects and health-related outcomes after allogeneic hematopoietic stem cell transplantation in childhood
Sammanfattning : Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment for many acquired or congenital disorders of the hematopoietic system. For some patients it may be the only curative option. LÄS MER
5. Immune reconstitution after allogeneic hematopoietic stem cell transplantation
Sammanfattning : After treatment with allogeneic hernatopoietic stem cell transplantation (HSCT) the patient suffers from a deficient immune system for at least 12 months or longer. During this period, the patient is susceptible to infections and if the state of immune deficiency is prolonged there is an increased risk of relapse of the underlying malignancy as well as development of secondary malignancies. LÄS MER